References

  1. Gardner P, Eickhoff T, Poland GA, et al. Adult immunizations. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):35-40.
  2. Gardner P, Schaffner W. Immunization of adults. N Engl J Med. 1993 Apr 29;328(17):1252-8. doi: 10.1056/NEJM199304293281708.
  3. Lu PJ, O'Halloran A, Kennedy ED, et. al. Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015. Vaccine. 2017 May 25;35(23):3104-3115. doi: 10.1016/j.vaccine.2017.04.028. Epub 2017 Apr 28.
  4. Centers for Disease Control (CDC). Vaccine Recommendations and Guidelines of the ACIP.  Accessed July 6, 2021.
  5. Occupational exposure to bloodborne pathogens--OSHA. Final rule. Fed Regist. 1991 Dec 6;56(235):64004-182. Accessed July 6, 2021.
  6. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011 Nov 25;60(RR-7):1-45.
  7. National Institute for Allergy and Infectious Diseases. Vaccine Types. Accessed July 6, 2021.
  8. National Institute for Allergy and Infectious Diseases. Vaccine Adjuvants. Accessed July 6, 2021.
  9. Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.
  10. Kotton CN, Hohmann EL. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun. 2004 Oct;72(10):5535-47. doi: 10.1128/IAI.72.10.5535-5547.2004.
  11. Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. 2017 Mar;139(3S):S1-S46. doi: 10.1016/j.jaci.2016.09.023. Epub 2016 Dec 29.
  12. Centers for Disease Control (CDC). National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.Morb Mortal Wkly Rep. 1988 Apr 8;37(13):197-200.
  13. Centers for Disease Control (CDC). Vaccine Contraindications and Precautions. Accessed July 6, 2021.
  14. Eggesbø M, Botten G, Halvorsen R, et al. The prevalence of allergy to egg: a population-based study in young children. Allergy. 2001 May;56(5):403-11.
  15. Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S470-5. doi: 10.1016/j.jaci.2005.05.048.
  16. Savage JH, Matsui EC, Skripak JM, et al. The natural history of egg allergy. J Allergy Clin Immunol. 2007 Dec;120(6):1413-7. doi: 10.1016/j.jaci.2007.09.040.
  17. Centers for Disease Control (CDC). Viral Hepatitis Surveillance Report 2018 — Hepatitis B. Accessed July 6, 2021.
  18. Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals. Hepatitis B FAQs for Health Professionals. Accessed July 6, 2021.
  19. Centers for Disease Control (CDC). Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR Morb Mortal Wkly Rep. 1985 Mar 1;34(8):105-8, 113.
  20. The Medical Letter for Drugs and Therapeutics. Adult immunization. 2018;60(1546):73-82.
  21. Centers for Disease Control and Prevention. Influenza (Flu). Information for Health Professionals. Accessed July 6, 2021.
  22. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020–21 Influenza Season. MMWR Recomm Rep 2020;69(RR-8):1-28.
  23. The Medical Letter for Drugs and Therapeutics. Antiviral drugs for influenza for 2020-2021. 2020;62(1610):169-174.
  24. Centers for Disease Control and Prevention. Measles (Rubeola). Accessed July 6, 2021.
  25. Centers for Disease Control and Prevention. Mumps. About Mumps. Accessed July 6, 2021.
  26. Centers for Disease Control and Prevention. Rubella (German Measles, Three-Day Measles). Accessed July 6, 2021.
  27. DeStefano F, Shimabukuro TT. The MMR Vaccine and Autism. Annu Rev Virol. 2019 Sep 29;6(1):585-600. doi: 10.1146/annurev-virology-092818-015515. Epub 2019 Apr.
  28. Spencer JP, Trondsen Pawlowski RH, Thomas S. Vaccine Adverse Events: Separating Myth from Reality. Am Fam Physician. 2017 Jun 15;95(12):786-794.
  29. Centers for Disease Control and Prevention. Chickenpox (Varicella). About Chickenpox. Accessed July 6, 2021.
  30. Centers for Disease Control and Prevention. Shingles (Herpes Zoster). About Shingles (Herpes Zoster). Page last updated: May 1, 2014. Accessed July 6, 2021.
  31. Centers for Disease Control and Prevention. Tetanus. About Tetanus. Accessed July 6, 2021.
  32. Centers for Disease Control and Prevention. Diphtheria. About Diphtheria. Accessed July 6, 2021.
  33. Centers for Disease Control and Prevention. Pertussis (Whooping Cough). About Pertussis. Accessed July 6, 2021.
  34. Havers FP, Mono PL, Hunter P, et al. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019. Morb Mortal Wkly Rep 2020;69(3):77-83. Accessed July 6, 2021.
  35. Centers for Disease Control and Prevention. Human Papillomavirus (HPV). Accessed July 6, 2021.
  36. Food and Drug Administration. June 12, 2020 Approval Letter - Gardasil9. Accessed July 6, 2021.
  37. Food and Drug Administration. October 5, 2018 Approval Letter - Gardasil9. Accessed July 6, 2021.
  38. Centers for Disease Control (CDC). How COVID-19 spreads. Accessed July 6, 2021.
  39. Centers for Disease Control (CDC). Symptoms of coronavirus. Accessed July 6, 2021.
  40. Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057
  41. Centers for Disease Control (CDC). COVID-19. People at increased risk. Accessed July 6, 2021.
  42. The Medical Letter for Drugs and Therapeutics. Treatments Considered for COVID-19 (Updated June 30, 2021). Accessed July 6, 2021.
  43. Centers for Disease Control and Prevention. Meningococcal Disease. Accessed July 6, 2021.
  44. Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep 2020;69(RR-9):1-41
  45. Centers for Disease Control and Prevention. Pneumococcal Disease. Accessed July 6, 2021.
  46. Matanock A, Lee G, Gierke R, et al. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 2019;68(46):1069-1075
  47. Centers for Disease Control and Prevention. Hepatitis A Questions and Answers for Health Professionals. Accessed July 6, 2021.
  48. Kohn WG, Collins AS, Cleveland JL, et al. Guidelines for Infection Control in Dental Health-Care Settings — 2003. MMWR Recomm Rep 2003;52(RR-17):1-76. Accessed July 6, 2021.
  49. Centers for Disease Control and Prevention. Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Oral Health; March 2016. Accessed July 6, 2021.

Additional Resources

  • No Additional Resources Available